Clinical trials
Liver Cirrhosis trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 3 |
| 2005 | 1 |
| 2006 | 3 |
| 2009 | 3 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Terminated | 7 |
| Recruiting | 6 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sanofi | 6 |
| University of Alberta | 4 |
| Boehringer Ingelheim | 3 |
| Gilead Sciences | 3 |
| Arbor Research Collaborative for Health | 2 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 2 |
| University Health Network, Toronto | 2 |
| AstraZeneca | 1 |
| Atea Pharmaceuticals, Inc. | 1 |
| Axcella Health, Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Cirrhosis | 44 |
| Ascites | 8 |
| Non-alcoholic Fatty Liver Disease | 8 |
| Liver Diseases | 5 |
| Fibrosis | 4 |
| Hepatitis C | 4 |
| Hypertension, Portal | 4 |
| Fatty Liver | 3 |
| Cholangitis, Sclerosing | 2 |
| End Stage Liver Disease | 2 |
Trials
Showing 26 to 44 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.